JUBILANT INGREVIA LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 505.1 INR | +0.99% |
|
-0.12% | -0.69% |
| 14/05 | Transcript : Jubilant Ingrevia Limited, Q4 2024 Earnings Call, May 14, 2024 | |
| 14/05 | Jubilant Ingrevia Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 | CI |
| Sales 2024 | 4.14TCr 50Cr | Sales 2025 * | 4.77TCr 57Cr | Capitalization | 7.97TCr 96Cr |
|---|---|---|---|---|---|
| Net income 2024 | 182.9Cr 2.2Cr | Net income 2025 * | 266.8Cr 3.21Cr | EV / Sales 2024 | 1.74 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.67 x |
| P/E ratio 2024 |
39.2
x | P/E ratio 2025 * |
29.8
x | Employees | 2,295 |
| Yield 2024 |
1.1% | Yield 2025 * |
0.77% | Free-Float | 42.57% |
More Fundamentals
* Assessed data
More news
Latest transcript on Jubilant Ingrevia Limited
| 1 day | +0.33% | ||
| 1 week | -0.77% | ||
| Current month | +0.33% | ||
| 1 month | -8.66% | ||
| 3 months | +5.35% | ||
| 6 months | +14.64% | ||
| Current year | -1.34% |
1 week
491.00
518.00
1 month
491.00562.25
Current year
420.00581.70
1 year
399.00581.70
3 years
350.45838.75
5 years
241.30838.75
10 years
241.30838.75
| Managers | Title | Age | Since |
|---|---|---|---|
Deepak Jain
CEO | Chief Executive Officer | - | 01/23/01 |
| Chief Executive Officer | 60 | 13/98/13 | |
| Director of Finance/CFO | 35 | 16/21/16 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 67 | 06/21/06 | |
| Chairman | 71 | 06/21/06 | |
| Director/Board Member | 46 | 06/21/06 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 112 M€ | +4.61% | - | |
| 0.00% | 34 M€ | +3.86% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/24/03 | 505.1 | +0.99% | 221 781 |
| 31/24/31 | 500.2 | +0.31% | 115,810 |
| 30/24/30 | 498.6 | -0.33% | 224,647 |
| 29/24/29 | 500.2 | -0.71% | 331,620 |
| 28/24/28 | 503.8 | -0.37% | 265,141 |
Delayed Quote NSE India S.E., June 03, 2024 at 12:21 pm IST
More quotes
Jubilant Ingrevia Limited is an India-based integrated provider of life sciences products and solutions. The Company's segments include Speciality Chemicals, Nutrition and Health Solutions, and Chemical Intermediates. The Speciality Chemicals segment includes pyridine and picolines, fine chemicals, agro chemicals, and custom development and manufacturing organization. The Nutrition and Health Solutions segment includes nutrition and health ingredients, and animal and human nutrition health solutions. The Chemical Intermediates segment includes acetyls and speciality ethanol. Its agro chemicals business is focused on agro intermediates and agro actives, including insecticides, herbicides and fungicides. Its range of products includes nutritional ingredients, such as vitamin B3, vitamin B4, picolinates and premix formulations for both animal and human nutrition. The Company serves various industries, such as pharmaceutical, nutrition, agrochemical, consumer and industrial customers.
Sector
Specialty Chemicals
Calendar
16/07/2024
- Q1 2025 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
500.2
INR
Average target price
567
INR
Spread / Average Target
+13.37%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.34% | 95Cr | |
| +17.07% | 6.63TCr | |
| -0.29% | 4.85TCr | |
| +21.61% | 4.33TCr | |
| +27.43% | 2.74TCr | |
| +9.25% | 1.93TCr | |
| -2.14% | 1.66TCr | |
| +9.75% | 1.66TCr | |
| -15.01% | 1.44TCr | |
| -30.22% | 1.4TCr |
- Stock Market
- Equities
- JUBLINGREA Stock
